Overview
A well-established pharmaceutical formulation manufacturing unit in Karnal is available for acquisition, presenting an excellent opportunity for pharmaceutical companies, strategic investors, and contract manufacturing businesses. Operational for the past two years, the facility is spread across 1,000 sq. m. of land with an 11,000 sq. ft. built-up area. The company specializes in both third-party manufacturing and own-brand manufacturing and has built a distribution network of over 50 distributors. The plant has an installed production capacity of 5 lakh tablets and 2.5 lakh capsules per 8-hour shift and is currently operating at only 50% of its installed capacity, offering substantial scope for increasing production without major capital expenditure. The existing product portfolio includes high-quality tablets and capsules manufactured under stringent quality standards. Additionally, dedicated sections for ointments and liquid formulations are already available within the facility and can be made operational by installing new machinery. With significant spare capacity, expansion-ready infrastructure, and strong market potential, this business offers an outstanding opportunity to scale operations in India's fast-growing pharmaceutical manufacturing sector.
Business Details
Describe Property
N.A
Competition / Market
Yes
Products & Services
The company undertakes both third-party manufacturing and own-brand manufacturing, supported by a distribution network of over 50 distributors. The plant has an installed production capacity of 5 lakh tablets and 2.5 lakh capsules per 8-hour shift, enabling efficient large-scale manufacturing.
Growth Potential
Very High
Reason For Sale
Not able to handle
Financial Details
How the Acquisition Process Works
- 01Contact SellerContact Seller
- 02Teaser/Information MemorandumTeaser/Information Memorandum
- 03Valuation ReportValuation Report
- 04FinancialsFinancials
- 05Schedule an Advisory MeetingBook Your Consultation